Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study

Anais Brasileiros de Dermatologia（2022）

引用 0|浏览1

暂无评分

摘要

Findings demonstrate effectiveness and tolerability of icatibant in Brazilian HAE patients.

查看译文

关键词

Bradykinin,Bradykinin receptor,Brazil,Hereditary angioedema

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要